Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
BMC Cancer ; 22(1): 275, 2022 Mar 15.
Article in English | MEDLINE | ID: mdl-35291972

ABSTRACT

BACKGROUND: Treatment decision for recurrent symptomatic brain metastases (BM) is challenging with scarce data regarding surgical resection. We therefore evaluated the efficacy of surgery for pretreated, recurrent BM in a comprehensive multidisciplinary treatment setting. METHODS: In a retrospective single center study, patients were analyzed, who underwent surgical resection of recurrent BM between 2007 and 2019. Intracranial event-free survival (EFS) and overall survival (OS) were evaluated by Kaplan-Maier and Cox regression analysis. RESULTS: We included 107 patients with different primary tumor entities and individual previous treatment for BM. Primary tumors comprised non-small cell lung cancer (NSCLC) (37.4%), breast cancer (19.6%), melanoma (13.1%), gastro-intestinal cancer (10.3%) and other, rare entities (19.6%). The number of previous treatments of BM ranged from one to four; the adjuvant treatment modalities comprised: none, focal or whole brain radiotherapy, brachytherapy and radiosurgery. The median pre-operative Karnofsky Performance Score (KPS) was 70% (range 40-100) and improved to 80% (range 0-100) after surgery. The complication rate was 26.2% and two patients died during the perioperative period. Sixty-seven (62.6%) patients received postoperative local radio-oncologic and/or systemic therapy. Median postoperative EFS and OS were 7.1 (95%CI 5.8-8.2) and 11.1 (95%CI 8.4-13.6) months, respectively. The clinical status (postoperative KPS ≥ 70 (HR 0.27 95%CI 0.16-0.46; p < 0.001) remained the only independent factor for survival in multivariate analysis. CONCLUSIONS: Surgical resection of recurrent BM may improve the clinical status and thus OS but is associated with a high complication rate; therefore a very careful patient selection is crucial.


Subject(s)
Brain Neoplasms , Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Radiosurgery , Brain Neoplasms/secondary , Carcinoma, Non-Small-Cell Lung/pathology , Humans , Lung Neoplasms/pathology , Retrospective Studies
2.
J Mater Sci Mater Med ; 26(10): 245, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26411441

ABSTRACT

Bacterial nanocellulose (BNC) is chemically identical with plant cellulose but free of byproducts like lignin, pectin, and hemicelluloses, featuring a unique reticulate network of fine fibers. BNC sheets are mostly obtained by static cultivation. Now, a Horizontal Lift Reactor may provide a cost efficient method for mass production. This is of particular interest as BNC features several properties of an ideal wound dressing although it exhibits no bactericidal activity. Therefore, BNC was functionalized with the antiseptics povidone-iodine (PI) and polihexanide (PHMB). Drug loading and release, mechanical characteristics, biocompatibility, and antimicrobial efficacy were investigated. Antiseptics release was based on diffusion and swelling according to Ritger-Peppas equation. PI-loaded BNC demonstrated a delayed release compared to PHMB due to a high molar drug mass and structural changes induced by PI insertion into BNC that also increased the compressive strength of BNC samples. Biological assays demonstrated high biocompatibility of PI-loaded BNC in human keratinocytes but a distinctly lower antimicrobial activity against Staphylococcus aureus compared to PHMB-loaded BNC. Overall, BNC loaded with PHMB demonstrated a better therapeutic window. Moreover, compressive and tensile strength were not changed by incorporation of PHMB into BNC, and solidity during loading and release could be confirmed.


Subject(s)
Anti-Infective Agents, Local/administration & dosage , Biguanides/administration & dosage , Cellulose , Nanoparticles , Povidone-Iodine/administration & dosage , Acetobacteraceae/chemistry , Acetobacteraceae/metabolism , Anti-Infective Agents, Local/pharmacokinetics , Bandages , Biguanides/pharmacokinetics , Biocompatible Materials/chemistry , Biocompatible Materials/isolation & purification , Biomechanical Phenomena , Cell Line , Cellulose/chemistry , Cellulose/isolation & purification , Humans , Materials Testing , Nanoparticles/administration & dosage , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Povidone-Iodine/pharmacokinetics , Staphylococcus aureus/drug effects
3.
Langmuir ; 28(37): 13518-25, 2012 Sep 18.
Article in English | MEDLINE | ID: mdl-22925063

ABSTRACT

Bacterial nanocellulose (BNC) is an extraordinary biopolymer with a wide range of potential technical applications. The high specific surface area and the interconnected pore system of the nanofibrillar BNC network suggest applications as a carrier of catalysts. The present paper describes an in situ modification route for the preparation of a hybrid material consisting of BNC and photocatalytically active anatase (TiO(2)) nanoparticles (NPs). The influence of different NP concentrations on the BNC biosynthesis and the resulting supramolecular structure of the hybrids was investigated. It was found that the number of colony forming units (CFUs) and the consumption of glucose during biosynthesis remained unaffected compared to unmodified BNC. During the formation of the BNC network, the NPs were incorporated in the whole volume of the accruing hybrid. Their distribution within the hybrid material is affected by the anisotropic structure of BNC. The photocatalytic activity (PCA) of the BNC-TiO(2) hybrids was determined by methanol conversion (MC) under UV irradiation. These tests demonstrated that the NPs retained their PCA after incorporation into the BNC carrier structure. The PCA of the hybrid material depends on the amount of incorporated NPs. No alteration of the photocatalyst's efficiency was found during repeated PCA tests. In conclusion, the in situ integration of photocatalytically active NPs into BNC represents an attractive possibility to extend its fields of application to porous filtering media for drinking water purification and air cleaning.


Subject(s)
Cellulose/biosynthesis , Gluconacetobacter xylinus/metabolism , Nanostructures/chemistry , Titanium/metabolism , Biocatalysis , Cellulose/chemistry , Gluconacetobacter xylinus/chemistry , Photochemical Processes , Surface Properties , Titanium/chemistry , Ultraviolet Rays
4.
Biotechnol Bioeng ; 105(4): 740-7, 2010 Mar 01.
Article in English | MEDLINE | ID: mdl-19816981

ABSTRACT

A variety of approaches are available for generation of bacteria-produced nanocellulose (BNC) in different forms. BNC production under static cultivation conditions usually results in fleeces or foils, characterized by a homogeneous, three-dimensional network of nanofibers and a uniform surface. However, under static cultivation conditions in batch vessels, the widths and the lengths of the BNC sheets cultured are determined by the dimensions of the culture vessel. In this contribution, a novel, efficient process for a (semi-)continuous cultivation of planar BNC fleeces and foils with a freely selectable length and an adjustable height is presented. By means of comprehensive investigations, the comparability of the BNC harvested to that gained from static cultivation under batch conditions is demonstrated. A first estimation of the production costs further shows that this type of processing allows for significant cost reductions compared to static cultivation of BNC in Erlenmeyer flasks.


Subject(s)
Biotechnology/methods , Cellulose/analysis , Cellulose/biosynthesis , Gluconacetobacter xylinus/metabolism , Bioreactors , Biotechnology/economics , Biotechnology/instrumentation , Cellulose/ultrastructure , Equipment Design , Nanostructures/analysis
5.
Carbohydr Polym ; 106: 410-3, 2014 Jun 15.
Article in English | MEDLINE | ID: mdl-24721096

ABSTRACT

For the loading of the natural biopolymer bacterial nanocellulose (BNC) with drugs, usually an adsorption method has been described. In the present study, a high-speed loading technique based on vortexing was established for the incorporation of proteins in BNC as drug delivery system. Compared to the conventional technique, vortexing accomplished in 10 min the same protein loading capacity as the adsorption method in 24h with comparable protein distribution and protein stability. Vortex loaded BNC demonstrated a retarded protein release with a lower total amount of released protein after 168 h compared to the adsorption loaded BNC. This was correlated with a densification of the fiber network as shown by electron microscopy and a reduced water holding capacity. These observations offer the possibility to control the drug release by selection of the preparation technique.


Subject(s)
Acetobacteraceae/chemistry , Biocompatible Materials/chemistry , Cellulose/chemistry , Hydrogels/chemistry , Nanofibers/chemistry , Serum Albumin, Bovine/chemistry , Adsorption , Animals , Cattle , Cellulose/isolation & purification , Delayed-Action Preparations , Hydrophobic and Hydrophilic Interactions , Microscopy, Electron, Scanning , Rotation , Serum Albumin, Bovine/analysis , Serum Albumin, Bovine/pharmacokinetics , Viscosity
6.
Int J Pharm ; 471(1-2): 45-55, 2014 Aug 25.
Article in English | MEDLINE | ID: mdl-24792978

ABSTRACT

Although bacterial nanocellulose (BNC) may serve as an ideal wound dressing, it exhibits no antibacterial properties by itself. Therefore, in the present study BNC was functionalized with the antiseptic drug octenidine. Drug loading and release, mechanical characteristics, biocompatibility, and antimicrobial efficacy were investigated. Octenidine release was based on diffusion and swelling according to the Ritger-Peppas equation and characterized by a time dependent biphasic release profile, with a rapid release in the first 8h, followed by a slower release rate up to 96 h. The comparison between lab-scale and up-scale BNC identified thickness, water content, and the surface area to volume ratio as parameters which have an impact on the control of the release characteristics. Compression and tensile strength remained unchanged upon incorporation of octenidine in BNC. In biological assays, drug-loaded BNC demonstrated high biocompatibility in human keratinocytes and antimicrobial activity against Staphylococcus aureus. In a long-term storage test, the octenidine loaded in BNC was found to be stable, releasable, and biologically active over a period of 6 months without changes. In conclusion, octenidine loaded BNC presents a ready-to-use wound dressing for the treatment of infected wounds that can be stored over 6 months without losing its antibacterial activity.


Subject(s)
Acetobacteraceae/chemistry , Anti-Infective Agents, Local/administration & dosage , Bandages , Cellulose/chemistry , Drug Carriers/chemistry , Nanoparticles/chemistry , Pyridines/administration & dosage , Wound Infection/prevention & control , Acetobacteraceae/growth & development , Anti-Infective Agents, Local/pharmacology , Anti-Infective Agents, Local/toxicity , Cell Line , Cell Proliferation/drug effects , Cell Survival/drug effects , Cellulose/isolation & purification , Dose-Response Relationship, Drug , Drug Carriers/isolation & purification , Drug Liberation , Drug Storage , Humans , Imines , Inhibitory Concentration 50 , Keratinocytes/drug effects , Keratinocytes/pathology , Materials Testing , Microscopy, Electron, Scanning , Particle Size , Pyridines/pharmacology , Pyridines/toxicity , Staphylococcus aureus/drug effects , Surface Properties , Tensile Strength
7.
J Pharm Sci ; 102(2): 579-92, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23192666

ABSTRACT

Although bacterial nanocellulose (BNC) has reached enormous interest for biomedical applications because of its outstanding material properties, investigations about its potential as drug delivery system are very rare. In the present study, for the first time, the applicability of BNC as drug delivery system for proteins using serum albumin as model drug was systematically investigated. Additionally, never-dried BNC was compared with freeze-dried BNC. For both types of BNC, a dependency of concentration, temperature, time, and preswelling for albumin loading and release could be demonstrated. These findings indicated an overlay of diffusion- and swelling-controlled processes, which could be confirmed by Ritger-Peppas equation. Freeze-dried samples showed a lower uptake capacity for albumin than native BNC, which was found to be related to changes of the fiber network during the freeze drying process as demonstrated by electron microscopy and protein staining experiments. The integrity and biological activity of proteins could be retained during the loading and release processes, which was demonstrated by gel electrophoresis and the use of luciferase as biologically active molecule. In conclusion, hydrophilicity, high biocompatibility, and controllable drug loading and release render BNC an innovative and attractive biopolymer for controlled drug delivery.


Subject(s)
Cellulose/chemistry , Drug Delivery Systems/methods , Gluconacetobacter xylinus/chemistry , Nanoparticles/chemistry , Serum Albumin, Bovine/chemistry , Animals , Biopolymers/administration & dosage , Biopolymers/chemistry , Biopolymers/metabolism , Cattle , Cellulose/administration & dosage , Cellulose/metabolism , Gluconacetobacter xylinus/metabolism , Nanoparticles/administration & dosage , Particle Size , Serum Albumin, Bovine/administration & dosage , Serum Albumin, Bovine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL